With healthcare shifting its focus to personalized medicine, the non-invasive medical device market is witnessing breakthrough innovations. From external cardiac pacemakers to nanotechnology-based blood purifying systems, the non-invasive medical technology domain is evolving at a rapid pace. In the wake of these trends, the global market for non-invasive and minimally invasive medical devices and equipment is expected to reach $29.9 billion by 2024, with a CAGR of 7.1 percent.
The growth is especially driven by the increasing patient demand for diagnostic and surgical procedures that can deliver better outcomes while reducing pre- and post-procedure discomfort. Among the most exciting innovations in the non-invasive medical device market is the acoustic surgery approach, which leverages high-intensity ultrasound to operate on targets lying deep within the human body without affecting the surrounding tissues. This is among many revolutionary technologies ushering in a new era of safe and painless diagnostic and therapeutic procedures.
To put the spotlight on such key developments in the industry, MedTech Outlook features thought leadership articles from Marco Dolci, president of cardiopulmonary at LivaNova [NASDAQ:LIVN], William Jason Cole, CIO at Meritus Health, and Niklas Best, director and head of digital products (EMEA region) at Fresenius Medical Care [NYSE:FMS], who shed light on the recent medical device innovation, wearable technologies, and remote medical systems transforming the healthcare paradigm.
In this edition of MedTech Outlook magazine, we also bring to you the story of some of the top non-invasive device providers that deliver the best outcomes for their clients. In the list, NeuroStar, particularly, stands out for its advanced therapy based on focused magnetic pulses (similar to an MRI) for treating patients with depression.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the non-invasive device space. We would like to know your thoughts.